TREATMENT APPROACHES

Treatment Approaches to Tardive Dyskinesia

Listen in as Dr. Dawn Vanderhoef, a Medical Director of Medical Affairs at Neurocrine, and Dr. Kaylee Mehlman, a clinical geriatric pharmacist, share their insights on therapeutic approaches to tardive dyskinesia, exploring its pathophysiology, its impact on the lives of patients, and management strategies for clinicians.
This podcast is sponsored and co-developed by Neurocrine Biosciences, Inc. This podcast is for educational purposes only and is not intended to promote any specific product. Both speakers are Neurocrine employees, and Dr. Kaylee Mehlman served as a paid consultant at the time of recording in February 2024. The content reflects Dr. Mehlman’s clinical judgment and personal experience.
Empty space, drag to resize

MED-MI-TD-US-0245

Up Next
Treatment Guideline Recommendations for Tardive Dyskinesia
This slide presentation explores the evolution of treatment approaches for tardive dyskinesia (TD), tracing changes in clinical recommendations over time and outlining the current evidence-based treatment paradigm.
Up Next
Long-Term Care Spotlight: Tardive Dyskinesia
In this specialized course, we will address the unique challenges of managing tardive dyskinesia in long-term care (LTC) settings. Participants will learn more about recognizing the risk of TD and its impact on residents and caregivers, and learn more about best practices for managing TD in residents.
Want to Learn More? Explore Other Learning Paths
DIMD Fundamentals
Focus on VMAT2 Inhibitors

Your Resources on Tardive Dyskinesia and Other DIMDs

These free educational resources are sponsored and developed by Neurocrine Biosciences, Inc.
Discover TD®
In this interactive application, users can differentially diagnose and develop appropriate management plans for hypothetical, virtual patients with various movement disorders.
DIMD Course
Enroll in this free, virtual self-paced learning platform delving into various clinical aspects of the most common DRBA-induced movement disorders and earn a recognized certificate of completion. 

Media Platforms

TD Dialogues® Podcast
Hear from experts in insightful conversations as they discuss the challenges of recognizing TD and share real-world strategies to effectively support patients in managing symptoms.
Neurocrine Medical: Brave Science™ YouTube Channel
This channel features educational videos designed to further understanding of TD, including content on the proposed mechanism of disease in TD and differentiating TD from drug-induced parkinsonism.

Explore the DIMD Ecosystem Library

Want to explore our collection of DIMD educational resources on your own? Use the link below to view the full content library.
This educational content was sponsored and developed by Neurocrine Biosciences, Inc. This non-CME program is intended to provide general information about drug-induced movement disorders and not medical advice for any particular patient.

Copyright © 2026

MED-MI-TD-US-0276